Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer
10.3389/fmed.2017.00039
Saved in:
Main Authors: | , , , |
---|---|
Other Authors: | |
Format: | Article |
Language: | English |
Published: |
FRONTIERS MEDIA SA
2022
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/228507 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
id |
sg-nus-scholar.10635-228507 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-2285072024-11-10T08:31:36Z Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer Sundar, Raghav Chenard-Poirier, Maxime Collins, Dearbhaile Catherine Yap, Timothy A MEDICINE Dr Raghav Sundar Science & Technology Life Sciences & Biomedicine Medicine, General & Internal General & Internal Medicine precision medicine lung cancer targeted therapy imprecision clinical trials RANDOMIZED PHASE-II PREVIOUSLY TREATED PATIENTS CISPLATIN PLUS GEMCITABINE RECEPTOR TYROSINE KINASE TIVANTINIB ARQ 197 OPEN-LABEL EGFR MUTATION 1ST-LINE THERAPY DOUBLE-BLIND C-MET 10.3389/fmed.2017.00039 FRONTIERS IN MEDICINE 4 APR 2022-07-14T04:33:09Z 2022-07-14T04:33:09Z 2017-04-10 2022-07-06T08:43:40Z Article Sundar, Raghav, Chenard-Poirier, Maxime, Collins, Dearbhaile Catherine, Yap, Timothy A (2017-04-10). Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer. FRONTIERS IN MEDICINE 4 (APR). ScholarBank@NUS Repository. https://doi.org/10.3389/fmed.2017.00039 2296-858X https://scholarbank.nus.edu.sg/handle/10635/228507 en FRONTIERS MEDIA SA Elements |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
language |
English |
topic |
Science & Technology Life Sciences & Biomedicine Medicine, General & Internal General & Internal Medicine precision medicine lung cancer targeted therapy imprecision clinical trials RANDOMIZED PHASE-II PREVIOUSLY TREATED PATIENTS CISPLATIN PLUS GEMCITABINE RECEPTOR TYROSINE KINASE TIVANTINIB ARQ 197 OPEN-LABEL EGFR MUTATION 1ST-LINE THERAPY DOUBLE-BLIND C-MET |
spellingShingle |
Science & Technology Life Sciences & Biomedicine Medicine, General & Internal General & Internal Medicine precision medicine lung cancer targeted therapy imprecision clinical trials RANDOMIZED PHASE-II PREVIOUSLY TREATED PATIENTS CISPLATIN PLUS GEMCITABINE RECEPTOR TYROSINE KINASE TIVANTINIB ARQ 197 OPEN-LABEL EGFR MUTATION 1ST-LINE THERAPY DOUBLE-BLIND C-MET Sundar, Raghav Chenard-Poirier, Maxime Collins, Dearbhaile Catherine Yap, Timothy A Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer |
description |
10.3389/fmed.2017.00039 |
author2 |
MEDICINE |
author_facet |
MEDICINE Sundar, Raghav Chenard-Poirier, Maxime Collins, Dearbhaile Catherine Yap, Timothy A |
format |
Article |
author |
Sundar, Raghav Chenard-Poirier, Maxime Collins, Dearbhaile Catherine Yap, Timothy A |
author_sort |
Sundar, Raghav |
title |
Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer |
title_short |
Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer |
title_full |
Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer |
title_fullStr |
Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer |
title_full_unstemmed |
Imprecision in the Era of Precision Medicine in Non-Small Cell Lung Cancer |
title_sort |
imprecision in the era of precision medicine in non-small cell lung cancer |
publisher |
FRONTIERS MEDIA SA |
publishDate |
2022 |
url |
https://scholarbank.nus.edu.sg/handle/10635/228507 |
_version_ |
1821209407762989056 |